Assured Investment Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Assured Investment Management’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-13,751	Closed	-$244K	–	1424
2018 Q3	$244K	Buy	13,751 +2,692	+24%	+$46.2K	﹤0.01%	939
2018 Q2	$153K	Buy	+11,059	New	+$131K	﹤0.01%	1032

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Assured Investment Management's ECYT Position: Q4 2018 in Review

Assured Investment Management sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 13,751 shares — an estimated $244K sold.

Assured Investment Management first reported a position in ECYT in Q2 2018 and held it in 2 quarters. The position peaked at $244K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Assured Investment Management reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Assured Investment Management sold 13,751 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $244K.
Assured Investment Management first reported a position in Endocyte, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
Assured Investment Management's Endocyte, Inc. Common Stock position peaked at $244K in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Assured Investment Management's 13F filing for Q4 2018, filed 13 Feb 2019.